Element Genomics, Inc.
DURHAM, NC · Founded 2015 · CIK 0001681101 · Biotech · Acquired
CRISPR-based epigenetic reprogramming platform to convert naive T cells into regulatory T cells (Tregs) for preventing graft-versus-host disease
elementbiosciences.com →- Grants
- $446K
- 2 awards
- Sector median: 1
- Raised
- $4.8M
- 1 Form D · Nov 2016
- 119 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Platform Technology for High-Throughput Screening of Gene Regulatory Elements | $224,881 | |
| Private capital raised | Form D · SEC | $4,850,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Reprogrammed T Cells to prevent graft versus host disease | $221,507 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1524 | Phenzyme, Inc. | — | — |
| 1525 | Jabez Biosciences, Inc. | — | $3.9M |
| 1526 | DRAGONASE LLC | — | — |
| 1527 | Element Genomics, Inc. | — | $4.8M |
| 1528 | StabiLux Biosciences, Inc | — | $554K |
| 1529 | PGI HOLDING CORPORATION | — | — |
| 1530 | EUNOIA BIO TECH, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Gregory CrawfordDirector · Executive Officer
- Charles GersbachDirector · Executive Officer
- John OxaalDirector · Executive Officer
- Timothy ReddyDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.